Showing results (271-280 of 2,337) with videos related to
Sort By:
Pageof 234
Clinical Lung Cancer|May 16, 2009
Management and prognosis in synchronous solitary resected brain metastasis from non-small-cell lung cancerAlexander V Louie, George Rodrigues, Brian Yaremko, et al.Clinical Lung Cancer|May 16, 2009
Predictors of long-term survival in patients with lung cancer included in the randomized Spanish Lung Cancer Group 0008 phase II trial using concomitant chemoradiation with docetaxel and carboplatin plus induction or consolidation chemotherapyPilar Garrido, Rafael Rosell, Bartomeu Massutí, et al.Clinical Lung Cancer|May 16, 2009
PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage III non-small-cell lung cancer of other than predominantly squamous cell histologyEverett E Vokes, Suresh Senan, Joseph A Treat, et al.Clinical Lung Cancer|December 17, 2008
The role of targeting mammalian target of rapamycin in lung cancerSumanta Kumar Pal, Robert A Figlin, Karen L ReckampClinical Lung Cancer|December 17, 2008
Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cellsSteven G Gray, Nael Al-Sarraf, Anne-Marie Baird, et al.Clinical Lung Cancer|April 23, 2005
Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgeryEnriqueta Felip, Miquel Taron, Rafael Rosell, et al.Clinical Lung Cancer|April 23, 2005
Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancerSharona Sachs, Thomas V Bilfinger, Eugene Komaroff, et al.Clinical Lung Cancer|April 23, 2005
Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancerCorey J LangerClinical Lung Cancer|September 24, 2005
Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancerRafael R Manon, Hazim Jaradat, Rakesh Patel, et al.Clinical Lung Cancer|September 15, 2005
Targeting angiogenesis with vascular endothelial growth factor receptor small-molecule inhibitors: novel agents with potential in lung cancerHeather A Wakelee, Joan H SchillerPageof 234